Transaction #15205 · Form 4 · 0001227556-25-000007
OMNICELL, INC. · Exercise / conversion · Common Stock
OMNICELL, INC. · Transacted December 1, 2025 · Filed December 3, 2025
What does this filing report?
An SEC Form 4 filing for OMNICELL, INC. records an exercise / conversion involving Common Stock on December 1, 2025. The reported quantity was 28,250. The filing date is December 3, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- OMNICELL, INC.
- Company CIK
- 0000926326
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 28,250
- Reported price
- 27.7
- Reference value
- 782,525
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 414,898
- Ownership description
- Not reported
- SEC acceptance time
- Dec 3, 2025, 4:05 PM EST
- 10b5-1 indication
- Indicated in filing
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- LIPPS RANDALL A ↗
CHAIRMAN, PRESIDENT AND CEO · Director
CIK 0001227556
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025.
- F2
- The price reported in Column 4 is a weighted average price of $35.9679. The sold price range between $35.65 to $36.4746. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3
- Shares held in trust with Mr. Lipps' wife.
- F4
- Shares held in trust for the benefit of Mr. Lipps' children.
- F5
- The options were granted on 2/4/2016 with 25% vested on the one-year anniversary of the grant date and the reaming amount vesting ratably over a 36 month period. The options were fully vested on 2/4/2020.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.